The ACCC has signed off on waste management company Bingo’s proposed $578 million acquisition of waste collection and processing service Dial-a-Dump, with the regulator saying Bingo’s proposal to divest a waste processing facility alleviated its competition concerns.
Target Australia and Baby Bunting have agreed to pay penalties totalling $53,000 after being caught selling and marketing unsafe convertible strollers, the consumer watchdog said Wednesday.
The lead plaintiff in a class action alleging National Australia Bank pushed worthless credit card insurance onto its customers is disputing the bank’s claims that it had no power to negotiate the terms of the policies.
The ACCC his hinted at what could be a record year for competition matters, with ACCC Chairman Rod Sims vowing to refer more cartel investigations for criminal prosecution and promising cases against banks and construction companies are on the horizon.
AFT Pharmaceuticals has filed a lawsuit seeking to pre-empt competitor Reckitt Benckiser from pursuing a lawsuit against it over recent ads for its painkiller Maxigesic.
Unilever is not ready to put its long-running consumer case against competitor Beiersdorf to rest, filing a challenge to a ruling that Beiersdorf did not make misleading claims about its Nivea clinical strength deodorant products.
A Labor government would require the ACCC to conduct post-merger reviews to test claims made at the time the transaction was approved.
Ramsay Health Care has denied its conduct towards a group of surgeons seeking to open a rival clinic in Coffs Harbour, NSW was anti-competitive or a misuse of market power, telling the court on the first day of trial that the venture was doomed to fail.
Pitcher Partners just found another reason to challenge a ruling that it owes $5.6 million in damages for concealing an accounting error from a client — a ruling that socks it with $3.3 million in legal costs for its “deceit”.
The stakes will be high for the ACCC when the trial kicks off Monday in its case against Ramsay Health Care alleging the hospital giant misused its market power and engaged in exclusive dealing, after the competition regulator came up short in its last big misuse of market power case against pharmaceutical giant Pfizer.